Literature DB >> 32632473

Myxoid mesenchymal intraventricular brain tumour with EWSR1-CREB1 gene fusion in an adult woman.

Pedro Valente Aguiar1,2, Jorge Pinheiro3,4, Jorge Lima5,4,6, Rui Vaz7,5,8, Paulo Linhares7,5,8.   

Abstract

Myxoid mesenchymal tumours harbouring fusions between EWSR1 and the CREB family transcription factors have recently been described. Whether they represent a novel entity or a myxoid variant of angiomatoid fibrous histiocytoma (AFH) remains a matter of debate. We describe the case of a 58-year-old woman with a previous history of breast cancer that developed progressive neurological decline due to a large mass located in the left lateral ventricle of the brain. Histology revealed a mesenchymal tumour with multinodular growth, variable cellularity, prominent myxoid stroma and numerous amianthoid fibres. No evidence of pseudo-capsule or lymphoid cuffing was identified. RNA sequencing disclosed EWSR1-CREB1 gene fusion. Only 20 cases of intracranial mesenchymal tumours harbouring these translocations have been described, mostly in adolescents and young adults and with dural attachment. Occurrence in this age group and with intraventricular location has been even more rarely reported. A better understanding of tumour behaviour is needed to establish treatment guidelines and improve patient outcome.

Entities:  

Keywords:  Angiomatoid fibrous histiocytoma; EWSR1–CREB gene rearrangement; Intracranial; Myxoid mesenchymal tumours

Mesh:

Substances:

Year:  2020        PMID: 32632473     DOI: 10.1007/s00428-020-02885-7

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  1 in total

1.  Clinicopathological features of angiomatoid fibrous histiocytoma: a series of 21 cases with variant morphology.

Authors:  Huijuan Shi; Hui Li; Tiantian Zhen; Fenfen Zhang; Yu Dong; Wenhui Zhang; Anjia Han
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01
  1 in total
  7 in total

1.  An extracranial CNS presentation of the emerging "intracranial" mesenchymal tumor, FET: CREB-fusion positive.

Authors:  Arnault Tauziède-Espariat; Gaëlle Pierron; Delphine Guillemot; Chiara Benevello; Johan Pallud; Joseph Benzakoun; Lauren Hasty; Alice Métais; Fabrice Chrétien; Pascale Varlet
Journal:  Brain Tumor Pathol       Date:  2022-09-15       Impact factor: 3.154

2.  Clinicopathological and Genomic Features of Pediatric Intracranial Myxoid Mesenchymal Tumor with both of EWSR1-CREM Gene Fusion and MAP3K13 Mutation: A Case Report and Comparison with Adult Cases in the Literature.

Authors:  Minami Sasaki; Seiichiro Hirono; Yue Gao; Izumi Suda; Tomoo Matsutani; Masayuki Ota; Takashi Kishimoto; Jun-Ichiro Ikeda; Hideaki Yokoo; Yasuo Iwadate
Journal:  NMC Case Rep J       Date:  2022-05-18

3.  A novel SMARCA2-CREM fusion: expanding the molecular spectrum of intracranial mesenchymal tumors beyond the FET genes.

Authors:  Arnault Tauziède-Espariat; Gaëlle Pierron; Delphine Guillemot; Philipp Sievers; Dominique Cazals-Hatem; Thierry Faillot; Alexandre Roux; Joseph Benzakoun; Sophie Bockel; Nicolas Weinbreck; Lauren Hasty; Emmanuèle Lechapt; Fabrice Chrétien; Pascale Varlet
Journal:  Acta Neuropathol Commun       Date:  2021-10-29       Impact factor: 7.801

4.  Comprehensive genomic profiling of EWSR1/FUS::CREB translocation-associated tumors uncovers prognostically significant recurrent genetic alterations and methylation-transcriptional correlates.

Authors:  Josephine K Dermawan; Fabio Vanoli; Laurie Herviou; Yun-Shao Sung; Lei Zhang; Samuel Singer; William D Tap; Ryma Benayed; Tejus A Bale; Jamal K Benhamida; Brendan C Dickson; Cristina R Antonescu
Journal:  Mod Pathol       Date:  2022-03-28       Impact factor: 8.209

5.  Operative Technique: Angiomatoid Fibrous Histiocytoma-Unique Case and Management.

Authors:  David J Mazur-Hart; Brannan E O'Neill; Brandi W Pang; Melanie H Hakar; Matthew D Wood; Sachin Gupta; Christina M Sayama; Jesse J Liu; Aclan Dogan
Journal:  J Neurol Surg Rep       Date:  2022-09-20

6.  Intracranial mesenchymal tumor with FET-CREB fusion-A unifying diagnosis for the spectrum of intracranial myxoid mesenchymal tumors and angiomatoid fibrous histiocytoma-like neoplasms.

Authors:  Emily A Sloan; Jason Chiang; Javier E Villanueva-Meyer; Sanda Alexandrescu; Jennifer M Eschbacher; Wesley Wang; Manuela Mafra; Nasir Ud Din; Emily Carr-Boyd; Michael Watson; Michael Punsoni; Angelica Oviedo; Ahmed Gilani; Bette K Kleinschmidt-DeMasters; Dylan J Coss; M Beatriz Lopes; Corey Raffel; Mitchel S Berger; Susan M Chang; Alyssa Reddy; Biswarathan Ramani; Sean P Ferris; Julieann C Lee; Jeffrey W Hofmann; Soo-Jin Cho; Andrew E Horvai; Melike Pekmezci; Tarik Tihan; Andrew W Bollen; Fausto J Rodriguez; David W Ellison; Arie Perry; David A Solomon
Journal:  Brain Pathol       Date:  2021-01-28       Impact factor: 6.508

7.  An integrative histopathological and epigenetic characterization of primary intracranial mesenchymal tumors, FET:CREB-fused broadening the spectrum of tumor entities in comparison with their soft tissue counterparts.

Authors:  Arnault Tauziède-Espariat; Philipp Sievers; Frédérique Larousserie; Joseph Benzakoun; Delphine Guillemot; Gaëlle Pierron; Mathilde Duchesne; Emmanuelle Uro-Coste; Alexandre Roux; Alexandre Vasiljevic; Tanguy Fenouil; David Meyronet; Karima Mokhtari; Marc Polivka; Audrey Rousseau; Frédérique Bost-Bezeaud; Samir Akoury; Johan Pallud; Chiara Benevello; Lauren Hasty; Albane Gareton; Emmanuèle Lechapt; Fabrice Chrétien; Thomas Blauwblomme; Kévin Beccaria; Stéphanie Puget; Felix Sahm; Pascale Varlet
Journal:  Brain Pathol       Date:  2021-07-27       Impact factor: 6.508

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.